GGrantIndex
Sort

40,608 grants matching prostate cancer

NEW AWARD: TARGETING THE DRIVERS OF ANDROGEN RECEPTOR PATHWAY-INDEPENDENT PROSTATE CANCER...EFFECTIVE 7/1/2020 SIGNED 1/17/2020, DISTRIBUTED 1/22/2020, FAADC 1/22/2020

$350,781
Fred Hutchinson Cancer Research Center · · FY2020 · Defense Health Agency

Protein Biomarker Arrays for Personalized Treatment of Prostate Cancer

$350,772
James F. Rusling · University Of Connecticut Storrs · R01 · FY2014 · EB

Molecular biomarkers of selenium chemoprevention

$350,767
Roswell Park Cancer Institute Corp · R01 · FY2003 · CA

N-3 Fatty Acid-Induced Akt Suppression: Chemoprevention for Pancreatic Neoplasia

$350,748
Paul Joseph Grippo · University Of Illinois At Chicago · R01 · FY2016 · CA

Genome-wide mapping and characterization of exitrons in human cancer

$350,705
Rendong Yang · Northwestern University At Chicago · R01 · FY2023 · CA

Deterministic Radiotherapy Dose Calculation Method

$350,685
Todd A Wareing · Transpire, Inc. · R44 · FY2008 · CA

Microtubule dependent AR signaling predicts taxane sensitivity

$350,675
Paraskevi Giannakakou · Weill Medical Coll Of Cornell Univ · R01 · FY2009 · CA

Regulation of Cellular Senescence and Oncogenic Transformation by Sin3B.

$350,675
Gregory David · New York University School Of Medicine · R01 · FY2012 · CA

Microtubule dependent AR signaling predicts taxane sensitivity

$350,675
Paraskevi Giannakakou · Weill Medical Coll Of Cornell Univ · R01 · FY2010 · CA

The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer

$350,675
Richard Bernard Hayes · New York University School Of Medicine · R01 · FY2011 · CA

The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer

$350,675
Richard Bernard Hayes · New York University School Of Medicine · R01 · FY2012 · CA

Regulation of Cellular Senescence and Oncogenic Transformation by Sin3B.

$350,675
Gregory David · New York University School Of Medicine · R01 · FY2015 · CA

The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer

$350,675
Richard Bernard Hayes · New York University School Of Medicine · R01 · FY2015 · CA

Whole Genome Sequencing to Discover Familial Myeloma Risk Genes

$350,675
Steven Monroe Lipkin · Weill Medical Coll Of Cornell Univ · R01 · FY2015 · CA

Regulation of Cellular Senescence and Oncogenic Transformation by Sin3B.

$350,675
Gregory David · New York University School Of Medicine · R01 · FY2011 · CA

Novel Radioimmunotherapy Strategies for Prostate Cancer

$350,651
Aaron Matthew Lebeau · University Of Minnesota · R01 · FY2019 · CA

Novel Radioimmunotherapy Strategies for Prostate Cancer

$350,651
Aaron Matthew Lebeau · University Of Minnesota · R01 · FY2020 · CA

Disrupting tumor/bone malignant interactions with multifunctional cytokine sonodelivery

$350,644
Marxa L. Figueiredo · Purdue University · R01 · FY2017 · CA

Project 2: Targeting N-Myc and EZH2-driven Castrate Resistant Prostate Cancer

$350,628
David S. Rickman · Weill Medical Coll Of Cornell Univ · P50 · FY2017 · CA

Function of TbRIII as a BMP Co-receptor in Human Cancer

$350,612
Gerard C Blobe · Duke University · R01 · FY2012 · CA

Modeling US Prostate Cancer Trends: PSA, Treatment & Ra*

$350,604
Ruth D Etzioni · Fred Hutchinson Cancer Research Center · U01 · FY2009 · CA

Target MIC shedding to revive anti-tumor immunity

$350,581
Jennifer D Wu · Northwestern University At Chicago · R01 · FY2019 · CA

Role of NF90 in Prostate Cancer

$350,581
Jindan Yu · Northwestern University At Chicago · R01 · FY2019 · CA

Understanding Resistance to Next Generation Antiandrogens

$350,544
Charles L Sawyers · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA

Lymphatic Imaging

$350,531
Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA